The research group "Cell Biology" investigates the biology of adult stem cells, immune cells, endothelial precursors and fibroblasts as well as their possible role in musculoskeletal tissue regeneration. We are looking at the interaction between cells, mechanics and the extracellular matrix. Furthermore, we are concentrating on alterations of intrinsic cell functions in response to extrinsic stimuli, such as age or an altered immune response. Our long-term goal is to develop new therapeutic approaches to improve musculoskeletal tissue regeneration, especially for impaired healing cases.
You are here:
The process of endogenous bone fracture repair restores prefractured properties and functions under optimal conditions. However, under certain constraints such as severe trauma, enhanced age, steroid therapy, or diabetes, this process can be delayed and may even result in incomplete healing and poor long-term outcome. About 5 to 15% of patients suffer from such complications after a fracture. These patients require additional surgery, which is associated with prolonged hospitalization and rehabilitation time and results in a high socioeconomic impact.
Currently, no reliable methods exist to prospectively identify patients at risk of impaired fracture healing. This may be a result of the wide interindividual variability in the degree of the injury, the associated soft tissue trauma, the patient’s compliance, the differences in anatomical reconstruction, and the inflammatory response at the onset of healing.
In addition to mesenchymal cells, immune cells are crucial for the endogenous regeneration of mesenchymal tissues even in the absence of infection. We previously found a relation between individual’s immune reactivity, the function of bone precursor cells (Mesenchymal Stromal Cells, MSCs) and disturbed fracture healing in humans. Our study revealed that compromised fracture healing is significantly correlated with enhanced levels of circulating terminally differentiated CD8+ effector memory T (TEMRA) cells. These cells were enriched in the hematoma and are major producers of TNF-α and IFN-γ, which inhibit osteogenic differentiation and survival of human MSCs (Fig.). To further investigate a causal relation between the enrichment of TEMRA cells, compromised MSC function, and the pathogenesis of poor bone fracture healing, we specifically depleted CD8+ T-cells in vivo by an antibody therapy. This treatment resulted in an enhanced endogenous fracture repair, whereas a transfer of CD8+ T-cells impaired the healing process. Our current data are the foundation of two ongoing studies (i) prospective validation of the biomarker CD8+ TEMRA cells in a large clinical (multi-center) trial, and (ii) the pharmacologically blocking the circulating CD8+ TEMRA cells or their cytokines to enhance fracture healing.
- Authors:Gisbert-Garzarán M, Berkmann JC, Giasafaki D, Lozano D, Spyrou K, Manzano M, Steriotis T, Duda GN, Schmidt-Bleek K, Charalambopoulou G, Vallet-Regí MJournal:ACS Appl Mater Interfaces Year:2020;
- Authors:Garske DS, Schmidt-Bleek K, Ellinghaus A, Dienelt A, Gu L, Mooney DJ, Duda G, Cipitria A
Journal:Tissue Eng Part A Year:2020;
Title:Alginate Hydrogels for In Vivo Bone Regeneration: The Immune Competence of the Animal Model Matters
- Authors:Stefanowski J, Lang A, Rauch A, Aulich L, Köhler M, Fiedler AF, Buttgereit F, Schmidt-Bleek K, Duda GN, Gaber T, Niesner RA Hauser AE1,2.
Journal:Front Immunol Year:2019; Volume:10
Title:Spatial Distribution of Macrophages During Callus Formation and Maturation Reveals Close Crosstalk Between Macrophages and Newly Forming Vessels
- Authors:Schlundt C, Reinke S, Geissler S, Bucher CH, Giannini C, Märdian S, Dahne M, Kleber C, Samans B, Baron U, Duda GN, Volk HD, Schmidt-Bleek KJournal:Front Immunol Year:2019; Volume:10
- Authors:Jirkof P, Durst M, Klopfleisch R, Palme R, Thöne-Reineke C, Buttgereit F, Schmidt-Bleek K, Lang A
Journal:Sci Rep Year:2019; Volume:9Issue:(1)
Title:Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model.
- Authors:Sbierski-Kind J, Schmidt-Bleek K, Streitz M, Kath J, Spranger J, Volk HJournal:J Vis Exp Year:2019; Volume:Apr 26;(146). doi: 10.3791/59470
- Authors:Bucher C, Schlundt C, Wulsten D, Sass F, Wendler S, Ellinghaus A, Thiele T, Seemann R, Willie B, Volk H, Duda G, Schmidt-Bleek KJournal:Front Immunol Year:2019; Volume:10:Pages:797.
- Authors:Wendler S, Schlundt C, Bucher CH, Birkigt J, Schipp CJ, Volk HD, Duda GN, Schmidt-Bleek K
Journal:Front Immunol Year:2019; Volume:10:Pages:713.
Title:Immune Modulation to Enhance Bone Healing-A New Concept to Induce Bone Using Prostacyclin to Locally Modulate Immunity
- Authors:Lang A, Kirchner M, Stefanowski J, Durst M, Weber MC, Pfeiffenberger M, Damerau A, Hauser AE, Hoff P, Duda GN, Buttgereit F, Schmidt-Bleek K, Gaber T
Journal:Acta Biomater Year:2019; Volume:86:Pages:171-184.
Title:Collagen I-based scaffolds negatively impact fracture healing in a mouse-osteotomy-model although used routinely in research and clinical application
- Authors:Petersen A, Princ A, Korus G, Ellinghaus A, Leemhuis H, Herrera A, Klaumunzer A, Schreivogel S, Woloszyk A, Schmidt-Bleek K, Geissler S, Heschel I, Duda GN
Journal:Nat Commun Year:2018; Volume:9Issue:(1):Pages:4430.
Title:A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects